Cul-de-sac fluid in women with endometriosis: fluid volume and prostanoid concentration during the proliferative phase of the cycle--days 8 to 12. 1982

J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball

Cul-de-sac fluid from women with histologically confirmed endometriosis (n = 45) or with no evidence of endometriosis (n = 17) was removed during the proliferative phase of the menstrual cycle (days 8 to 12) and analyzed for prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF2 alpha), 15-keto-13,14-dihydroprostaglandin F2 alpha (PGFM), and thromboxane B2 (TXB2). The fluid volume was recorded. Peripheral blood was also obtained to determine the concentration of PGFM. Prostanoid concentrations (PGE2, PGF2 alpha, PGFM, TXB2) in women with endometriosis were not significantly different from a comparable group of disease-free women. Furthermore, a meaningful elevation of prostanoid with increasing severity of disease could not be demonstrated. Plasma PGFM was not significantly different from controls. There was, however, an elevation of PGFM with severity of disease, although this increase was not statistically significant (P = 0.11). An increase in fluid volume was not demonstrated in women with endometriosis, as compared with controls.

UI MeSH Term Description Entries
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D013931 Thromboxanes Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Thromboxane

Related Publications

J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
November 1987, Nihon Sanka Fujinka Gakkai zasshi,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
February 1990, Fertility and sterility,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
January 1967, Bulletin de la Federation des societes de gynecologie et dobstetrique de langue francaise,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
March 2005, Radiology,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
July 1991, The Journal of reproductive medicine,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
August 1997, The Journal of the American Association of Gynecologic Laparoscopists,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
January 2002, Likars'ka sprava,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
October 1988, The Journal of reproductive medicine,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
January 1990, Progress in clinical and biological research,
J A Rock, and N H Dubin, and R B Ghodgaonkar, and C A Bergquist, and Y S Erozan, and A W Kimball
February 1992, American journal of obstetrics and gynecology,
Copied contents to your clipboard!